Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
Fresh frozen plasma becomes frozen plasma after when
|
a. 1 year 52 |
|
Was a difference noted with TEG when comparing fresh frozen plasma to frozen plasma
|
a. No, the plasma remained hemostaticall active when evaluated by TEG for 5 years b. Although not clinically significant, factors VIII, X were lower in frozen plasma compared to FFP, OSPT and APTT were longer and fibrinogen was lower, AT was increased 53 |
|
What percentage of humans with nephrotic syndrome experience thromboembolic complications
|
a. 42% 54 |
|
What is the reported percentage of thromboembolic complications in dogs with PLN
|
a. 22% 55 |
|
Are antithrombin levels, UPC, or serum albumin levels predictive of dogs that will experience thromboembolic complications
|
a. No 56 |
|
What is the one test that can measure hypercoagulability
|
a. TEG 57 |
|
Dogs with PLN were more or less hypercoagulable when compared to controls
|
a. More hypercoagulable 58 |
|
What was the proposed mechanism for hypercoagulability in dogs with PLN
|
a. Interaction between platelets and fibrin amplification and propagation phases of clot formation (in the study was not influenced by PCV or platelet count) 59 |
|
Humans with PLN have been found to have what factors to promote hypercoagulability
|
a. Decreased AT, increased platelets, increased platelet activation, increased fibrinogen, increased factors V and VIII, increased vonwillebrands factor, and vascular stasis 60 |
|
What is the mechanism of action behind IMTP
|
a. Antibodies form against platelets leading to their destruction/phagocytosis by macrophages 61 |
|
At what level does spontaneous hemorrhage occur
|
a. 30-50K 62 |
|
Is there any difference in hospital time or platelet recovery time in dogs that received prednisone + vincristine vs. prednisone + IVIG
|
a. No, was the same, median hospitalization was 4 days and platelet recovery time was 2.5 days 63 |
|
What is the overall mechanism of action for vincristine
|
a. Vinca alkaloid that inhibits microtubule formation (binds to tubulin) of the mitotic spindle and thereby inhibits cellular division b. Mechanism behind increasing platelets is unknown but theorized to expedite thrombopoiesis and decreased phagocytosis of opsonized platelets 64 |
|
What are the adverse side effects from vincristine
|
a. Myelosuppression, phlebitis if extravasated 65 |
|
What is the MOA for IVIG
|
a. Binds to the Fc receptor on mononuclear cells 66 |
|
What are the adverse effects of IVIG
|
a. Fever, anaphylaxis, thrombocytopenia 67 |
|
What is a type 2 error
|
a. When a statistical difference cannot be obtained despite its existence because of small sample size 68 |
|
IMHA is what type of autoimmune response
|
a. Type 2 because antibody mediated 69 |
|
What is the cutoff value for spherocytes in supporting IMHA
|
a. 5 per HPF 70 |
|
What doses of GCC have been reported to have a higher rate of side effects/ complications with little benefit
|
a. 2 mg/kg BID 71 |
|
What are the two most common 2nd tier drugs reported as therapy for IMHA
|
a. Cyclosporine and Azathioprine 72 |
|
Which immunosuppressive is NOT recommended
|
a. Cyclophosphamide 73 |
|
Is there published evidence that conclusively supports using azathioprine vs. cyclosporine
|
a. No, conflicting studies that show GCC are just as effective by themselves 74 |
|
What two drugs are reported to have better clinical outcomes when used in the treatment of IMHA
|
a. Heparin, aspirin 75 |
|
When using TEG, dogs with CPSS were considered hypo or hypercoagulable
|
a. Hypercoagulable as they had shorter k values, steeper angles, and increased MA 76 |
|
What clinical attribute was associated with dogs with CPSS to be hypercoagulable
|
a. If they had hepatic encephalopathy 77 |
|
What is the proposed mechanism behind dogs that were hypercoagulable
|
a. Increased bacterial translocation secondary to hepatic encephalopathy, leading to systemic inflammation; altered vascular flow 78 |
|
Was PT or aPTT predictive of those dogs that would be hypercoagulable
|
a. No, was often prolonged-> fibrinogen concentration more closely mirrored it 79 |
|
What percentage of dogs with IMHA have evidence of thrombi on necropsy
|
a. 80% 80 |
|
What are antiphospholipid antibodies
|
a. Antibodies (immunoglobulins) that target phospholipids or proteins that bind to phospholipids 81 |
|
What is antiphospholipid syndrome
|
a. Human condition characterized by autoimmune disease that has increased evidence of recurrent thrombosis 82 |
|
Did dogs with IMHA, spontaneous thrombosis, and HAC have increased levels of antiphospholipids compared to controls
|
a. Yes 83 |
|
Is there an association between antiphospholipid antibodies and dogs that develop thromboembolic complications
|
a. No 84 |
|
What is Scott Syndrome
|
a. Impaired externalization of phosphatidylserine of the platelet and therefore lack of prothrombinase- develop a predisposition to bleeding (postoperative and nontraumatic bleeding) 85 |
|
How does one diagnose Scott Syndrome
|
a. Will see altered platelet aggregation under arteriolar flow, indicating platelet dysfunction- all coags, vonWillebrand factor, and TEG will be normal 86 |
|
What breed of dogs are susceptible to Scott Syndrome
|
a. German Shepherd, autosomal recessive inheritance, affects males > females 87 |
|
What antibody is most commonly involved in IMTP and what proteins are targeted on the platelet
|
a. IgG; glycoprotein IIb and IIIa 88 |
|
What vaccine is commonly associated with IMTP in people
|
a. Measles, mumps, rubella (MMR)- can cause a nadir at 21 days of as low as 1K platelets 89 |
|
What veterinary vaccines have been associated with thrombocytopenia
|
a. Distemper and hepatitis vaccines, rarely go below 100K 90 |
|
Is there evidence that vaccines cause IMTP in veterinary medicine
|
a. No 91 |
|
What prostaglandin has been shown to reversibly inhibit platelet activation
|
a. PGE1 92 |
|
How does this prostaglandin inhibit platelet activation
|
a. Increases cAMP concentrations 93 |
|
How does the addition of PGE1 to platelet concentrates help with making platelet rich plasma
|
a. Decreases platelet activation and made platelet resuspension easier and faster, did not affect hemostasis when the product was dilted in plasma 94 |
|
What is a Sonoclot
|
a. Cage-side device that can measure blood viscosity and evaluate entire hemostasis process quantitatively and qualitatively 95 |
|
When heparin was used in dogs and the dogs were monitored with the Sonoclot, which other test closely mirrored the results of the sonoclot
|
a. aPTT (both were sensitive and specific) |